These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37845287)

  • 1. A radiomics model based on magnetic resonance imaging to predict cytokeratin 7/19 expression and liver fluke infection of hepatocellular carcinoma.
    Liu JQ; Wang J; Huang XL; Liang TY; Zhou X; Mo ST; Xie HX; Yang KJ; Zhu GZ; Su H; Liao XW; Long LL; Peng T
    Sci Rep; 2023 Oct; 13(1):17553. PubMed ID: 37845287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma.
    Hu X; Wang Q; Huang G; He X; Sparrelid E; Brismar TB; Fan Y
    Comput Math Methods Med; 2023; 2023():5424204. PubMed ID: 36814805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
    Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
    Chen Y; Chen J; Zhang Y; Lin Z; Wang M; Huang L; Huang M; Tang M; Zhou X; Peng Z; Huang B; Feng ST
    J Hepatocell Carcinoma; 2021; 8():795-808. PubMed ID: 34327180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
    Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.
    Huang K; He Y; Liang T; Mo S; Liao Y; Gao Q; Liao X; Han C; Zhu G; Peng T
    Sci Rep; 2024 Feb; 14(1):3314. PubMed ID: 38332165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence.
    Uenishi T; Kubo S; Yamamoto T; Shuto T; Ogawa M; Tanaka H; Tanaka S; Kaneda K; Hirohashi K
    Cancer Sci; 2003 Oct; 94(10):851-7. PubMed ID: 14556657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
    Durnez A; Verslype C; Nevens F; Fevery J; Aerts R; Pirenne J; Lesaffre E; Libbrecht L; Desmet V; Roskams T
    Histopathology; 2006 Aug; 49(2):138-51. PubMed ID: 16879391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.
    Huang X; Long L; Wei J; Li Y; Xia Y; Zuo P; Chai X
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2995-3003. PubMed ID: 31664520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiomics nomogram for predicting cytokeratin 19-positive hepatocellular carcinoma: a two-center study.
    Zhang L; Zhou H; Zhang X; Ding Z; Xu J
    Front Oncol; 2023; 13():1174069. PubMed ID: 37182122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy.
    Qin SD; Zhang J; Qi YP; Zhong JH; Xiang BD
    World J Surg Oncol; 2022 Jun; 20(1):209. PubMed ID: 35725470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of MRI in predicting hepatocellular carcinoma with cytokeratin 19 expression: a systematic review and meta-analysis.
    Qin Q; Deng LP; Chen J; Ye Z; Wu YY; Yuan Y; Song B
    Clin Radiol; 2023 Dec; 78(12):e975-e984. PubMed ID: 37783612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients.
    Liu LZ; Yang LX; Zheng BH; Dong PP; Liu XY; Wang ZC; Zhou J; Fan J; Wang XY; Gao Q
    J Surg Oncol; 2018 Jun; 117(7):1531-1539. PubMed ID: 29513894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of cytokeratin(CK)7, CK8/18, CK19 and p40 in esophageal squamous cell carcinoma and their correlation with prognosis].
    Yang ZY; Zhang HY; Wang F; Ma YH; Li YY; He HL; Wang C; Li SS
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):834-839. PubMed ID: 30423606
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
    Lee SH; Lee JS; Na GH; You YK; Kim DG
    Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27653235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study.
    Yang F; Wan Y; Xu L; Wu Y; Shen X; Wang J; Lu D; Shao C; Zheng S; Niu T; Xu X
    Front Oncol; 2021; 11():672126. PubMed ID: 34476208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas.
    Hu XX; Wang WT; Yang L; Yang ZX; Liang HY; Ding Y; Ji Y; Zeng MS; Rao SX
    Eur J Radiol; 2019 Apr; 113():7-14. PubMed ID: 30927962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.